The typical initiation dose is 2.5 mg weekly for four weeks, with gradual titration every four weeks based on individual response and tolerability
(1) to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with type 2 diabetes mellitus who are at high risk for these events
However, it is essential for researchers to follow proper guidelines when dosing Semaglutide
Prompt action required : If a patient on semaglutide reports sudden vision loss or rapid impairment, they should immediately contact their physician, and treatment should be discontinued if NAION is confirmed
If side effects become difficult, your prescriber may consider holding at a current dose longer, reviewing meals, or reassessing whether the medicine remains suitable